What are the responsibilities and job description for the Principal Associate I/II, Plant Quality Assurance position at Replimune?
Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.
Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other .
People are at the center of everything we do, and when it comes to our employees , we make it personal . With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients .
Join us, as we reshape the future.
Job Summary:
The Principal Associate I/II, Plant Quality Assurance (PQA) reports to the Associate Director, Quality Assurance and is responsible for on-going Quality oversight to ensure real time quality oversight for Drug Substance, Drug Product, and all other production and QC testing activities according to current good manufacturing practices (cGMP), good documentation practices (GDP) and other applicable regulations. This position will be required to proactively support cGMP compliance and interact with all departments within the company. This position interacts with production staff and other cross functional groups routinely.
This position is based in our Framingham location and typically has a 5-day on-site expectation.
Responsibilities
Key responsibilities:
Education:
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com .
We are an Equal Opportunity Employer.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.
Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other .
People are at the center of everything we do, and when it comes to our employees , we make it personal . With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients .
Join us, as we reshape the future.
Job Summary:
The Principal Associate I/II, Plant Quality Assurance (PQA) reports to the Associate Director, Quality Assurance and is responsible for on-going Quality oversight to ensure real time quality oversight for Drug Substance, Drug Product, and all other production and QC testing activities according to current good manufacturing practices (cGMP), good documentation practices (GDP) and other applicable regulations. This position will be required to proactively support cGMP compliance and interact with all departments within the company. This position interacts with production staff and other cross functional groups routinely.
This position is based in our Framingham location and typically has a 5-day on-site expectation.
Responsibilities
Key responsibilities:
- Serve as the second shift QA lead working alongside manufacturing teams to ensure current and best practices are implemented, consistently maintaining compliance with cGMP standards and keeping the plant in compliance with corporate and regulatory quality requirements.
- Perform Quality walkthroughs and inspections on the floor, to maintain inspection readiness environment.
- Review and approve executed production batch records, logbooks, and QC Assays.
- Drive closure/completion (including review and approve) of cGMP documents and records, including but not limited to deviations, investigations, corrective action/preventative actions (CAPA), change control records and validation documentation.
- Author/review/approve quality documents, such as: standard operating procedures (SOPs), user requirements, risk assessments, training materials, engineering documents, automation documents, commissioning test protocols/reports, environmental qualification protocols/reports, validation protocols/reports.
- Conduct training on procedures, standard work, safety, and cGMP related topics.
- Internal and external audit and inspection support as needed
- Assist with the implementation and continuous improvement of the Quality System.
- Other duties, as assigned
Education:
- BA or BS in a Science or related field or equivalent experience in the Quality function.
- 5-7 years of experience in the pharmaceutical field including 5 years of years of Quality or Manufacturing experience
- Experience in managing multiple, competing priorities in a fast-paced environment.
- Demonstrated proficiency of written and verbal communication skills (including technical writing and presentations)
- Previous Quality Assurance oversight experience
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com .
We are an Equal Opportunity Employer.
